Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators

Bibliography

• Lefkowitz RJ. Seven transmembrane receptors: something old, something new. Acta Physiol (Oxf) 2007;190:9-19
   PubMed Web of Science ®Google Scholar
• Franco R, Ciruela F, Casadó V, Partners for adenosine A1 receptors. J Mol Neurosci 2005;26:221-32
   PubMed Web of Science ®Google Scholar
• Kunishima N, Shimada Y, Tsuji Y, Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000;407:971-7
   PubMed Web of Science ®Google Scholar
• Nelson G, Hoon MA, Chandrashekar J, Mammalian sweet taste receptors. Cell 2001;106:381-90
   PubMed Web of Science ®Google Scholar
• Rasmussen SG, Choi HJ, Rosenbaum DM, Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007;450:383-7
   PubMed Web of Science ®Google Scholar
• Rosenbaum DM, Cherezov V, Hanson MA, GPCR engineering yields high-resolution structural insights into beta2 adrenergic receptor function. Science 2007;318:1266-73
   PubMed Web of Science ®Google Scholar
• Kobilka BK, Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 2007;28:397-406
   PubMed Web of Science ®Google Scholar
• Jaakola VP, Griffith MT, Hanson MA, The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist. Science 2008;322:1211-7
   PubMed Web of Science ®Google Scholar
• Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2001;2:274-86
   PubMed Web of Science ®Google Scholar
• Rios CD, Jordan BA, Gomes I, Devi LA. G protein-coupled receptor dimerization: modulation of receptor function. Pharmacol Ther 2001;92:71-87
   PubMed Web of Science ®Google Scholar
• George SR, O'Dowd BF, Lee SP. G protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 2002;1:808-20
   PubMed Web of Science ®Google Scholar
• Franco R, Canals M, Marcellino D, Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. Trends Biochem Sci 2003;28:238-43
   PubMed Web of Science ®Google Scholar
• Franco R, Casadó V, Mallol J, Dimer-based model for heptaspanning membrane receptors. Trends Biochem Sci 2005;30:360-6
   PubMed Web of Science ®Google Scholar
• Franco R, Casadó V, Cortés A, G protein-coupled receptors heteromers:function and ligand pharmacology. Br J Pharmacol 2008;153:S90-8
   PubMed Web of Science ®Google Scholar
• Milligan G. G protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discov Today 2006;11:541-9
   PubMed Web of Science ®Google Scholar
• Maggio R, Innamorati G, Parenti M. G protein-coupled receptor oligomerization provides the framework for signal discrimination. J Neurochem 2007;103:1741-52
   PubMed Web of Science ®Google Scholar
• Maurel D, Comps-Agrar L, Brock C, Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods 2008;5:561-7
   PubMed Web of Science ®Google Scholar
• Ferré S, Baler R, Bouvier M, Building a new conceptual framework for receptor heteromers. Nature Chem Biol 2009;5:131-4
   PubMed Web of Science ®Google Scholar
• Casadó V, Cortés A, Mallol J, GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers? Pharmacol Ther 2009a;124:248-57
   PubMed Web of Science ®Google Scholar
• Casadó V, Ferrada C, Bonaventura J, Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation. Biochem Pharmacol 2009b;78:1456-63
   PubMed Web of Science ®Google Scholar
• Kostenis E. G proteins in drug screening: from analysis of receptor-G protein specificity to manipulation of GPCR-mediated signalling pathways. Curr Pharm Des 2006;12:1703-15
   PubMed Web of Science ®Google Scholar
• Chung S, Funakoshi T, Civelli O. Orphan GPCR research. Br J Pharmacol 2007;153(Suppl 1):S339-46
   PubMedGoogle Scholar
• Levoye A, Dam J, Ayoub MA, The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J 2006;25:3012-23
   PubMed Web of Science ®Google Scholar
• Johansson B, Halldner L, Dunwiddie TV, Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 2001;98:9407-12
   PubMed Web of Science ®Google Scholar
• Gui L, Duan W, Tian H, Adenosine A 2A receptor deficiency reduces striatal glutamate outflow and attenuates brain injury induced by transient focal cerebral ischemia in mice. Brain Res 2009;1297:185-93
   PubMed Web of Science ®Google Scholar
• Niswender CM, Johnson KA, Luo Q, A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors. Mol Pharmacol 2008;73:1213-24
   PubMed Web of Science ®Google Scholar
• Christopoulos A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 2002;1:198-210
   PubMed Web of Science ®Google Scholar
• Oldham WM, Hamm HE. Structural basis of function in heterotrimeric G proteins. Q Rev Biophys 2006;39:117-66
   PubMed Web of Science ®Google Scholar
• May LT, Christopoulos A. Allosteric modulators of G-protein-coupled receptors. Curr Opin Pharmacol 2003;3:551-6
   PubMed Web of Science ®Google Scholar
• Gilchrist A. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics. Trends Pharmacol Sci 2007;28:431-7
   PubMed Web of Science ®Google Scholar
• Bridges TM, Lindsley CW. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms. ACS Chem Biol 2008;3:530-41
   PubMed Web of Science ®Google Scholar
• Lazareno S, Birdsall NJM. Detection, quantitation, and veri?cation of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 1995;48:362-78
   PubMed Web of Science ®Google Scholar
• Christopoulos A. Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays. In Current Protocols in Pharmacology. Edited by Enna SJ New York: Wiley and Sons; 2000: 1.22.21-21.22.40
   Google Scholar
• Kenakin T. Functional selectivity in GPCR modulator screening. Comb Chem High Throughput Screen 2008;11:337-43
   PubMed Web of Science ®Google Scholar
• Jacob L, Hoffmann B, Stoven V, Virtual screening of GPCRs: an in silico chemogenomics approach. BMC Bioinformatics 2008;9:363
   PubMed Web of Science ®Google Scholar
• Eglen RM, Reisine T. New insights into GPCR function: implications for HTS. Methods Mol Biol 2009;552:1-13
   PubMedGoogle Scholar
• Amatruda TT III, Steele DA, Slepak VZ, G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells. Proc Natl Acad Sci USA 1991;88:5587-91
   PubMed Web of Science ®Google Scholar
• Liu AM, Ho MK, Wong CS, Galpha(16/z) chimeras efficiently link a wide range of G-protein-coupled receptors to calcium mobilization. J Biomol Screen 2003;8:39-49
   PubMed Web of Science ®Google Scholar
• Hazari A, Lowes V, Chan JH, Replacement of the alpha5 helix of Galpha16 with Galpha-specific sequences enhances promiscuity of Galpha16 toward Gs-coupled receptors. Cell Signal 2004;16:51-62
   PubMed Web of Science ®Google Scholar
• Pfleger KD Eidne KA. Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells. Biochem J 2005;385:625-37
   PubMed Web of Science ®Google Scholar
• Doucette C, Vedvik K, Koepnick E, Kappa opioid receptor screen with the tangoTM beta-arrestin recruitment technology and characterization of hits with second-messenger assays. J Biomol Screen 2009;14:381-94
   PubMed Web of Science ®Google Scholar
• Vilardaga JP, Bünemann M, Krasel C, Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nature Biotech 2003;21:807-12
   PubMed Web of Science ®Google Scholar
• Lee PH. Label-free optical biosensor: a tool for G protein-coupled receptors pharmacology profiling and inverse agonists identification. J Recept Signal Transduct Res 2009;29:146-53
   PubMed Web of Science ®Google Scholar
• Tran E, Fang Y. Label-free optical biosensor for probing integrative role of adenylyl cyclase in G protein-coupled receptor signalling. J Recept Signal Transduct Res 2009;29:154-62
   PubMed Web of Science ®Google Scholar
• Leifert WR, Aoia AL, Bucco O, G-protein-coupled receptors in drug discovery: nanosizing using cell-free technologies and molecular biology approaches. J Biomol Screening 2005;10:765-79
   PubMed Web of Science ®Google Scholar
• Casadó V, Cortés A, Ciruela F, Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index. Pharmacol Ther 2007;16:343-54
   Google Scholar
• Shih JC, Young H. The alteration of serotonin binding sites in aged human brain. Life Sci 1978;23:1441-8
   PubMed Web of Science ®Google Scholar
• De Lean A, Stadel JM, Lefkowitz RJ. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase- coupled b-adrenergic receptor. J Biol Chem 1980;255:7108-17
   PubMed Web of Science ®Google Scholar
• Casadó V, Cantí C, Mallol J, Solubilization of A1 adenosine receptor from pig brain: characterization and evidence of the role of the cell membrane on the coexistence of high- and low-affinity states. J Neurosci Res 1990;26:461-73
   PubMed Web of Science ®Google Scholar
• Saharan RS, Nantwi KD. Changes in the biochemical profiles of mid-cervically located adenosine A1 receptors alter repeated theophilline administration in adult rats. J Spinal Cord Med 2006;29:520-6
   PubMed Web of Science ®Google Scholar
• Brandon CI, Vandenplas M, Linden J, Murray TF. Cloning and pharmacological characterization of the equine adenosine A2A receptor: a potential therapeutic target for the treatment of equine endotoxemia. J Vet Pharmacol Ther 2006;29:243-53
   PubMed Web of Science ®Google Scholar
• Kenakin T. Data-driven analysis in drug discovery. J Recept Signal Transduct Res 2006a;26:299-327
   PubMed Web of Science ®Google Scholar
• Miller WE, Lefkowitz RJ. Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signalling and trafficking. Curr Opin Cell Biol 2001;13:139-45
   PubMed Web of Science ®Google Scholar
• Angers S, Salahpour A, Joly E, Detection of beta2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 2000;97:3684-9
   PubMed Web of Science ®Google Scholar
• Overton MC, Blumer KJG. Protein coupled receptors function as oligomers in vivo. Curr Biol 2000;10:341-4
   PubMed Web of Science ®Google Scholar
• Agnati LF, Ferré S, Lluis C, Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 2003;55:509-50
   PubMed Web of Science ®Google Scholar
• Milligan G, Bouvier M. Methods to monitor the quaternary structure of G-protein-coupled receptors. FEBS J 2005;272:2914-25
   PubMed Web of Science ®Google Scholar
• Pfleger KD, Eidne KA. Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer. Nat Methods 2006;3:165-74
   PubMed Web of Science ®Google Scholar
• Pfleger KD, Dromey JR, Dalrymple MB, Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. Cell Signal 2006;18:1664-70
   PubMed Web of Science ®Google Scholar
• Ayoub MA, Pfleger KD. Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. Curr Opin Pharmacol 2010;10:44-52
   Google Scholar
• Charest PG, Terrillon S, Bouvier M. Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET. EMBO Rep 2005;6:334-40
   PubMed Web of Science ®Google Scholar
• Vagner J, Xu L, Handl HL, Heterobivalent ligands crosslink multiple cell-surface receptors: the human melacortin-4 and delta-opioid receptors. Angew Chem 2008;47:1685-8
   Web of Science ®Google Scholar
• Xu L, Vagner J, Josan J, Enhanced targeting with heterobivalent ligands. Mol Cancer Ther 2009;8:2358-65
   Google Scholar
• Soriano A, Ventura R, Molero A, Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers. J Med Chem 2009;52:5590-602
   PubMed Web of Science ®Google Scholar
• Guo W, Urizar E, Kralikova M, Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J 2008;27:2293-304
   PubMed Web of Science ®Google Scholar
• Carriba P, Navarro G, Ciruela F, Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods 2008;5:727-33
   PubMed Web of Science ®Google Scholar
• Navarro G, Carriba P, Gandía J, Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. Scientific WorldJournal 2008;8:1088-97
   PubMed Web of Science ®Google Scholar
• Cabello N, Gandía J, Bertarelli DC, Metabotropic glutamate Type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. J Neurochem 2009;109:1497-507
   PubMed Web of Science ®Google Scholar
• Han Y, Moreira IS, Urizar E, Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol 2009;5:688-95
   PubMed Web of Science ®Google Scholar
• Dalrymple MB, Pfleger KD, Eidne KA. G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol Ther 2008;118:359-71
   PubMed Web of Science ®Google Scholar
• Rashid AJ, So CH, Kong MM, D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 2007;104:654-9
   PubMed Web of Science ®Google Scholar
• So CH, Varghese G, Curley KJ, D1 and D2 dopamine receptors form hetero oligomers and cointernalize after selective activation of either receptor. Mol Pharmacol 2005;68:568-78
   PubMed Web of Science ®Google Scholar
• Hasbi A, O'Dowd BF, George SR. Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signalling by different mechanisms. Curr Opin Pharmacol 2010;10:93-9
   Google Scholar
• Maggio R, Barbier P, Colelli A, G protein-linked receptors: Pharmacological evidence for the formation of heterodimers. J Biol Chem 1999;291:251-7
   Google Scholar
• Ciruela F, Casadó V, Rodrigues RJ, Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 2006;26:2080-7
   PubMed Web of Science ®Google Scholar
• Ferré S, Ciruela F, Woods AS, Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci 2007;30:440-6
   PubMed Web of Science ®Google Scholar
• Franco R, Casadó V, Cortés A, Basic concepts in G-protein-coupled receptor homo- and heterodimerization. Scientific WorldJournal 2007;7:48-57
   PubMedGoogle Scholar
• González-Maeso J, Ang RL, Yuen T, Identification of a serotonin/glutamate receptor complex implicated in psycosis. Nature 2008;452:93-9
   PubMed Web of Science ®Google Scholar
• Ferrada C, Moreno E, Casadó V, Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol 2009;157(1):64-75
   PubMed Web of Science ®Google Scholar
• Tomassini N, Renaud FL, Roy S, Loh HH. Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages. J Neuroimmunol 2003;136:9-16
   PubMed Web of Science ®Google Scholar
• Levac BA, O'Dowd BF, George SR. Oligomerization of opioid receptors: generation of novel signaling units. Curr Opin Pharmacol 2002;2(1):76-81
   PubMed Web of Science ®Google Scholar
• van Rijn RM, Whistler JL, Waldhoer M. Opioid-receptor-heteromer-specific trafficking and pharmacology. Curr Opin Pharmacol 2010;10:73-9
   Google Scholar
• Franco R, Casadó V, Mallol J, The two-state dimer receptor model: a general model for receptor dimers. Mol Pharmacol 2006;69:1905-12
   PubMed Web of Science ®Google Scholar
• Soudijn W, Van Wijngaarden I, IJzerman AP. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments. Drug Discov Today 2004;9:752-8
   PubMed Web of Science ®Google Scholar
• Kenakin T, Jenkinson S, Watson C. Determining the potency and molecular mechanisms of action of unsourmontable antagonists. J Pharmacol Exper Ther 2006b;319:710-23
   PubMed Web of Science ®Google Scholar
• Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 2004;3:353-9
   PubMed Web of Science ®Google Scholar
• Morphy R, Kay C, Rankovic Z. From magic bullets to designed multiple ligands. Drug Discov Today 2004;9:641-51
   PubMed Web of Science ®Google Scholar
• Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends in Pharmacological Sciences 2005;26:178-82
   PubMed Web of Science ®Google Scholar
• Barbey S, Goosens L, Taverne T, Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor. Bioorg Med Chem Lett 2002;12:779-82
   PubMed Web of Science ®Google Scholar
• Lambright DG, Sondek J, Bohm A, The 2.0 A crystal structure of a heterotrimeric G protein. Nature 1996;379:297-9
   PubMedGoogle Scholar